Frequent loss of 1p32 region but no mutation if the p18 tumor suppressor gene in meningiomas

被引:25
作者
Leuraud, P
Marie, Y
Robin, E
Huguet, S
He, J
Mokhtari, K
Cornu, P
Khê, HX
Sanson, M
机构
[1] Hop La Pitie Salpetriere, Federat Neurol Mazarin, F-75013 Paris 13, France
[2] Hop La Pitie Salpetriere, INSERM, U495, Paris, France
[3] Hop La Pitie Salpetriere, Lab Neuropathol R Escourolle, F-75651 Paris, France
[4] Hop La Pitie Salpetriere, Serv Neurochirurg, Paris, France
[5] Fac Med Pitie Salpetriere, Lab Histol Embryol Cytogenet, Paris, France
关键词
meningioma; chromosome; 1; p18; CDKN2C;
D O I
10.1023/A:1006400723490
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
After chromosome 22 and NF2 inactivation, the loss of chromosome 1p is one of the most frequent abnormalities encountered in meningiomas. However the putative tumor suppressor gene located on 1p inactivated in meningiomas has still to be identified. We screened 68 meningiomas for LOH on chromosome 22 and 1. We found 34 LOH on the NF2 region on chromosome 22 (50%) and 19 LOH on 1p (28%), 16 being associated with loss of chromosome 22. Partial deletions delimited a candidate region located between D1S234 and D1S2797. The p18 tumor suppressor gene, a member of the genes family coding for inhibitors of cyclin-dependent kinases, is located in this region. To determine whether p18 is involved in development of meningiomas, we performed a mutation analysis of the p18 gene and a search for homozygous deletion in the 19 meningiomas with 1p loss. Sequencing analysis of the p18 gene revealed one polymorphism, but no somatic mutations and no homozygous deletions were found. These results confirm that the loss of chromosome 1p32 is a frequent feature in meningiomas, however the p18 tumor suppressor gene which is located in this region, does not seem to be involved.
引用
收藏
页码:207 / 213
页数:7
相关论文
共 35 条
[1]   Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancer [J].
Blais, A ;
Labrie, Y ;
Pouliot, F ;
Lachance, Y ;
Labrie, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (01) :146-153
[2]   Deletion mapping of the short arm of chromosome 1 identifies a common region of deletion distal to D1S496 in human meningiomas [J].
Bostrom, J ;
Muhlbauer, A ;
Reifenberger, G .
ACTA NEUROPATHOLOGICA, 1997, 94 (05) :479-485
[3]  
DUMANSKI JP, 1990, CANCER RES, V50, P5863
[4]   GROWTH SUPPRESSION BY P18, A P16(INK4/MTS1)-RELATED AND P14(INK4B/MTS2)-RELATED CDK6 INHIBITOR, CORRELATES WITH WILD-TYPE PRB FUNCTION [J].
GUAN, KL ;
JENKINS, CW ;
LI, Y ;
NICHOLS, MA ;
WU, XY ;
OKEEFE, CL ;
MATERA, AG ;
XIONG, Y .
GENES & DEVELOPMENT, 1994, 8 (24) :2939-2952
[5]   P18 tumor suppressor gene and progression of oligodendrogliomas to anaplasia [J].
He, J ;
Hoang-Xuan, K ;
Marie, Y ;
Leuraud, P ;
Mokhtari, K ;
Kujas, M ;
Delattre, JY ;
Sanson, M .
NEUROLOGY, 2000, 55 (06) :867-869
[6]   Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors [J].
Husemann, K ;
Wolter, M ;
Büschges, R ;
Boström, J ;
Sabel, M ;
Reifenberger, G .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (10) :1041-1050
[7]  
Iolascon A, 1996, LEUKEMIA, V10, P255
[8]  
Iolascon A, 1996, GENE CHROMOSOME CANC, V15, P217, DOI 10.1002/(SICI)1098-2264(199604)15:4<217::AID-GCC3>3.0.CO
[9]  
2-4
[10]  
Kawamata N, 1996, CANCER, V77, P570